Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Res

Retrieve available abstracts of 202 articles:
HTML format



Single Articles


    November 2022
  1. LI W, Wang B, Tan M, Song X, et al
    Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
    Respir Res. 2022;23:321.
    PubMed     Abstract available


  2. FEIZI H, Alizadeh M, Nejadghaderi SA, Noori M, et al
    The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990-2019.
    Respir Res. 2022;23:319.
    PubMed     Abstract available


  3. MA L, Zhu M, Li G, Gai J, et al
    Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma.
    Respir Res. 2022;23:316.
    PubMed     Abstract available


  4. WANG WW, Mao B, Liu Y, Gu SY, et al
    Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.
    Respir Res. 2022;23:317.
    PubMed     Abstract available


  5. WILSON AC, Bon JM, Mason S, Diaz AA, et al
    Increased chest CT derived bone and muscle measures capture markers of improved morbidity and mortality in COPD.
    Respir Res. 2022;23:311.
    PubMed     Abstract available


  6. TEJWANI V, Woo H, Liu C, Tillery AK, et al
    Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS.
    Respir Res. 2022;23:310.
    PubMed     Abstract available


  7. LU J, Ge H, Qi L, Zhang S, et al
    Subtyping preserved ratio impaired spirometry (PRISm) by using quantitative HRCT imaging characteristics.
    Respir Res. 2022;23:309.
    PubMed     Abstract available


  8. GRIBBEN KC, Wyss AB, Poole JA, Farazi PA, et al
    CC16 polymorphisms in asthma, asthma subtypes, and asthma control in adults from the Agricultural Lung Health Study.
    Respir Res. 2022;23:305.
    PubMed     Abstract available


    October 2022
  9. ZHAO N, Wu F, Peng J, Zheng Y, et al
    Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity.
    Respir Res. 2022;23:298.
    PubMed     Abstract available


  10. WANG R, Li W, Dai H, Zhu M, et al
    PKD1 deficiency induces Bronchiectasis in a porcine ADPKD model.
    Respir Res. 2022;23:292.
    PubMed     Abstract available


  11. XIA M, Xu F, Ni H, Wang Q, et al
    Neutrophil activation and NETosis are the predominant drivers of airway inflammation in an OVA/CFA/LPS induced murine model.
    Respir Res. 2022;23:289.
    PubMed     Abstract available


  12. CHOI H, Kim SH, Han K, Park TS, et al
    Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis.
    Respir Res. 2022;23:288.
    PubMed     Abstract available


  13. RAO X, Dong H, Zhang W, Sun H, et al
    MiR-493-5p inhibits Th9 cell differentiation in allergic asthma by targeting FOXO1.
    Respir Res. 2022;23:286.
    PubMed     Abstract available


  14. JACOBS M, Verschraegen S, Salhi B, Anckaert J, et al
    IL-10 producing regulatory B cells are decreased in blood from smokers and COPD patients.
    Respir Res. 2022;23:287.
    PubMed     Abstract available


  15. CASADEVALL C, Sancho-Munoz A, Vicente I, Pascual-Guardia S, et al
    Influence of COPD systemic environment on the myogenic function of muscle precursor cells in vitro.
    Respir Res. 2022;23:282.
    PubMed     Abstract available


  16. ANDREAS A, Maloy A, Nyunoya T, Zhang Y, et al
    The FoxP1 gene regulates lung function, production of matrix metalloproteinases and inflammatory mediators, and viability of lung epithelia.
    Respir Res. 2022;23:281.
    PubMed     Abstract available


  17. HUSSAIN SS, Edwards YJK, Libby EF, Stanford D, et al
    Comparative transcriptomics in human COPD reveals dysregulated genes uniquely expressed in ferrets.
    Respir Res. 2022;23:277.
    PubMed     Abstract available


  18. YI F, Zhan C, Liu B, Li H, et al
    Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
    Respir Res. 2022;23:279.
    PubMed     Abstract available


  19. JIANG T, Hu W, Zhang S, Ren C, et al
    Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis.
    Respir Res. 2022;23:269.
    PubMed     Abstract available


  20. PAULIN LM, Halenar MJ, Edwards KC, Lauten K, et al
    Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study.
    Respir Res. 2022;23:273.
    PubMed     Abstract available


    September 2022
  21. FALLAHZADEH A, Sharifnejad Tehrani Y, Sheikhy A, Ghamari SH, et al
    The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019.
    Respir Res. 2022;23:268.
    PubMed     Abstract available


  22. DIVO MJ, Marin JM, Casanova C, Cabrera Lopez C, et al
    Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease.
    Respir Res. 2022;23:267.
    PubMed     Abstract available


  23. XU J, Sun X, Zhu H, Cao Y, et al
    Long-term variability of impulse oscillometry and spirometry in stable COPD and asthma.
    Respir Res. 2022;23:262.
    PubMed     Abstract available


  24. DALEY-YATES P, Keppler B, Baines A, Bardsley G, et al
    Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.
    Respir Res. 2022;23:258.
    PubMed     Abstract available


  25. PEI Y, Wei Y, Peng B, Wang M, et al
    Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveal the cellular and genetic profiles in COPD.
    Respir Res. 2022;23:260.
    PubMed     Abstract available


  26. MAGWENZI P, Rusakaniko S, Sibanda EN, Gumbo FZ, et al
    Challenges in the diagnosis of asthma in children, what are the solutions? A scoping review of 3 countries in sub Saharan Africa.
    Respir Res. 2022;23:254.
    PubMed     Abstract available


  27. YAMADA H, Matsumoto I, Makita N, Arita Y, et al
    Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study.
    Respir Res. 2022;23:255.
    PubMed     Abstract available


  28. LIU Y, Shi G
    Roles of sirtuins in asthma.
    Respir Res. 2022;23:251.
    PubMed     Abstract available


  29. HUANG D, He D, Gong L, Yao R, et al
    A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease.
    Respir Res. 2022;23:250.
    PubMed     Abstract available


  30. GRIBBEN KC, Poole JA, Nelson AJ, Farazi PA, et al
    Relationships of serum CC16 levels with smoking status and lung function in COPD.
    Respir Res. 2022;23:247.
    PubMed     Abstract available


  31. LEUNG C, Ryu MH, Bolling AK, Maestre-Batlle D, et al
    Peroxisome proliferator-activated receptor gamma gene variants modify human airway and systemic responses to indoor dibutyl phthalate exposure.
    Respir Res. 2022;23:248.
    PubMed     Abstract available


  32. FENG KN, Meng P, Zou XL, Zhang M, et al
    IL-37 protects against airway remodeling by reversing bronchial epithelial-mesenchymal transition via IL-24 signaling pathway in chronic asthma.
    Respir Res. 2022;23:244.
    PubMed     Abstract available


  33. ZHOU J, Yi F, Wu F, Xu P, et al
    Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China.
    Respir Res. 2022;23:243.
    PubMed     Abstract available


  34. LENG S, Picchi MA, Meek PM, Jiang M, et al
    Wood smoke exposure affects lung aging, quality of life, and all-cause mortality in New Mexican smokers.
    Respir Res. 2022;23:236.
    PubMed     Abstract available


  35. LEE HW, Baek MG, Choi S, Ahn YH, et al
    Peripheral blood transcriptomic clusters uncovered immune phenotypes of asthma.
    Respir Res. 2022;23:237.
    PubMed     Abstract available


  36. KHODAYARI N, Oshins R, Mehrad B, Lascano JE, et al
    Cigarette smoke exposed airway epithelial cell-derived EVs promote pro-inflammatory macrophage activation in alpha-1 antitrypsin deficiency.
    Respir Res. 2022;23:232.
    PubMed     Abstract available


  37. LEE CH, Kim MS, Yeo SH, Rhee CK, et al
    Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
    Respir Res. 2022;23:231.
    PubMed     Abstract available


  38. ALTHOFF MD, Jimenez G, Peterson R, Jin Y, et al
    Differences in L-arginine metabolism and asthma morbidity among asthma patients with and without obstructive sleep apnea.
    Respir Res. 2022;23:230.
    PubMed     Abstract available


  39. DAI C, Wu F, Wang Z, Peng J, et al
    The association between small airway dysfunction and aging: a cross-sectional analysis from the ECOPD cohort.
    Respir Res. 2022;23:229.
    PubMed     Abstract available


    August 2022
  40. SU X, Wu W, Zhu Z, Lin X, et al
    The effects of epithelial-mesenchymal transitions in COPD induced by cigarette smoke: an update.
    Respir Res. 2022;23:225.
    PubMed     Abstract available


  41. SHIN S, Kong S, Kang D, Lee G, et al
    Longitudinal changes in pulmonary function and patient-reported outcomes after lung cancer surgery.
    Respir Res. 2022;23:224.
    PubMed     Abstract available


  42. ROGLIANI P, Cavalli F, Ritondo BL, Cazzola M, et al
    Sex differences in adult asthma and COPD therapy: a systematic review.
    Respir Res. 2022;23:222.
    PubMed     Abstract available


  43. KOMURA M, Sato T, Yoshikawa H, Nitta NA, et al
    Propylene glycol, a component of electronic cigarette liquid, damages epithelial cells in human small airways.
    Respir Res. 2022;23:216.
    PubMed     Abstract available


  44. HURST JR, Han MK, Singh B, Sharma S, et al
    Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.
    Respir Res. 2022;23:213.
    PubMed     Abstract available


  45. JO YS, Kim KJ, Rhee CK, Yoo KH, et al
    Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease.
    Respir Res. 2022;23:212.
    PubMed     Abstract available


  46. SMALLWOOD N, Pascoe A, Vogrin S, Philip J, et al
    SINFONIA study protocol: a phase II/III randomised controlled trial examining benefits of guided online group singing in people with chronic obstructive pulmonary disease and interstitial lung disease and their carers.
    Respir Res. 2022;23:208.
    PubMed     Abstract available


  47. DE LUCA G, Nardin M, Algowhary M, Uguz B, et al
    Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry.
    Respir Res. 2022;23:207.
    PubMed     Abstract available


  48. DI STEFANO A, Dossena F, Gnemmi I, D'Anna SE, et al
    Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease.
    Respir Res. 2022;23:200.
    PubMed     Abstract available


    July 2022
  49. BODUM KS, Hjerrild BE, Dalsgaard S, Rubak SLM, et al
    Behavioural side effects of inhaled corticosteroids among children and adolescents with asthma.
    Respir Res. 2022;23:192.
    PubMed     Abstract available


  50. KAN M, Sun M, Jiang X, Diwadkar AR, et al
    CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids.
    Respir Res. 2022;23:193.
    PubMed     Abstract available


  51. RIEG AD, Suleiman S, Anker C, Bunting NA, et al
    Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation.
    Respir Res. 2022;23:189.
    PubMed     Abstract available


  52. CHEN CH, Wu CD, Lee YL, Lee KY, et al
    Air pollution enhance the progression of restrictive lung function impairment and diffusion capacity reduction: an elderly cohort study.
    Respir Res. 2022;23:186.
    PubMed     Abstract available


  53. BIGNOLD R, Shammout B, Rowley JE, Repici M, et al
    Chemokine CXCL12 drives pericyte accumulation and airway remodeling in allergic airway disease.
    Respir Res. 2022;23:183.
    PubMed     Abstract available


  54. LEEM AY, Kim YS, Chung KS, Park MS, et al
    Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity.
    Respir Res. 2022;23:185.
    PubMed     Abstract available


  55. HOU J, Wang X, Su C, Ma W, et al
    Reduced frequencies of Foxp3(+)GARP(+) regulatory T cells in COPD patients are associated with multi-organ loss of tissue phenotype.
    Respir Res. 2022;23:176.
    PubMed     Abstract available


    June 2022
  56. GOUDARZI H, Kimura H, Kimura H, Makita H, et al
    Effects of obesity on CC16 and their potential role in overweight/obese asthma.
    Respir Res. 2022;23:174.
    PubMed     Abstract available


  57. SURAYA R, Nagano T, Ryanto GRT, Effendi WI, et al
    Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFkappaB inactivation.
    Respir Res. 2022;23:173.
    PubMed     Abstract available


  58. HONG Y, Deng M, Hu W, Zhang R, et al
    Weak cough is associated with increased mortality in COPD patients with scheduled extubation: a two-year follow-up study.
    Respir Res. 2022;23:166.
    PubMed     Abstract available


  59. LE NPK, do Nascimento AF, Schneberger D, Quach CC, et al
    Deficiency of leukocyte-specific protein 1 (LSP1) alleviates asthmatic inflammation in a mouse model.
    Respir Res. 2022;23:165.
    PubMed     Abstract available


  60. MARIN-OTO M, Sanz-Rubio D, Santamaria-Martos F, Benitez I, et al
    Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea.
    Respir Res. 2022;23:163.
    PubMed     Abstract available


  61. QIN W, Huang H, Dai Y, Han W, et al
    Proteome analysis of urinary biomarkers in a cigarette smoke-induced COPD rat model.
    Respir Res. 2022;23:156.
    PubMed     Abstract available


  62. LIU P, Wang Y, Zhang N, Zhao X, et al
    Comprehensive identification of RNA transcripts and construction of RNA network in chronic obstructive pulmonary disease.
    Respir Res. 2022;23:154.
    PubMed     Abstract available


  63. LOPEZ-CAMPOS JL, Osaba L, Czischke K, Jardim JR, et al
    Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis.
    Respir Res. 2022;23:152.
    PubMed     Abstract available


  64. SALO PM, Mendy A, Wilkerson J, Molsberry SA, et al
    Serum antioxidant vitamins and respiratory morbidity and mortality: a pooled analysis.
    Respir Res. 2022;23:150.
    PubMed     Abstract available


  65. SCHNEIDER S, Merfort I, Idzko M, Zech A, et al
    Blocking P2X purinoceptor 4 signalling alleviates cigarette smoke induced pulmonary inflammation.
    Respir Res. 2022;23:148.
    PubMed     Abstract available


  66. KIM SY, Lee HJ, Lee JK, Park TY, et al
    Association between oxygen saturation level during bronchoscopy and post-bronchoscopy adverse events: a retrospective cohort study.
    Respir Res. 2022;23:144.
    PubMed     Abstract available


    May 2022
  67. LEE H, Kovacs C, Mattman A, Hollander Z, et al
    The impact of IgG subclass deficiency on the risk of mortality in hospitalized patients with COPD.
    Respir Res. 2022;23:141.
    PubMed     Abstract available


  68. XIONG XF, Zhu M, Wu HX, Fan LL, et al
    Immunophenotype in acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.
    Respir Res. 2022;23:137.
    PubMed     Abstract available


  69. ALQARNI AA, Brand OJ, Pasini A, Alahmari M, et al
    Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation.
    Respir Res. 2022;23:136.
    PubMed     Abstract available


  70. IHRIE MD, McQuade VL, Womble JT, Hegde A, et al
    Exogenous leptin enhances markers of airway fibrosis in a mouse model of chronic allergic airways disease.
    Respir Res. 2022;23:131.
    PubMed     Abstract available


  71. PINCIKOVA T, Parrot T, Hjelte L, Hogman M, et al
    MAIT cell counts are associated with the risk of hospitalization in COPD.
    Respir Res. 2022;23:127.
    PubMed     Abstract available


  72. JACKSON D, Walum J, Banerjee P, Lewis BW, et al
    Th1 cytokines synergize to change gene expression and promote corticosteroid insensitivity in pediatric airway smooth muscle.
    Respir Res. 2022;23:126.
    PubMed     Abstract available


  73. ZHAN Y, Chen J, Wu J, Gu Y, et al
    Human epididymis protein 4 aggravates airway inflammation and remodeling in chronic obstructive pulmonary disease.
    Respir Res. 2022;23:120.
    PubMed     Abstract available


  74. HUANG K, Li F, Wang X, Yan B, et al
    Clinical and cytokine patterns of uncontrolled asthma with and without comorbid chronic rhinosinusitis: a cross-sectional study.
    Respir Res. 2022;23:119.
    PubMed     Abstract available


  75. LIU Y, Qu HQ, Qu J, Chang X, et al
    Burden of rare coding variants reveals genetic heterogeneity between obese and non-obese asthma patients in the African American population.
    Respir Res. 2022;23:116.
    PubMed     Abstract available


  76. FENG J, Sun L, Sun X, Xu L, et al
    Increasing prevalence and burden of bronchiectasis in urban Chinese adults, 2013-2017: a nationwide population-based cohort study.
    Respir Res. 2022;23:111.
    PubMed     Abstract available


  77. GALGANI I, Annaratone M, Casula D, Di Maro G, et al
    Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.
    Respir Res. 2022;23:114.
    PubMed     Abstract available


  78. KIM HS, An CH, Teller D, Moon SJ, et al
    The role of retinoid-related orphan receptor-alpha in cigarette smoke-induced autophagic response.
    Respir Res. 2022;23:110.
    PubMed     Abstract available


  79. MAGNUSSON JM, Ericson P, Tengvall S, Stockfelt M, et al
    Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation.
    Respir Res. 2022;23:108.
    PubMed     Abstract available


  80. VOGELMEIER CF, Worth H, Buhl R, Criee CP, et al
    Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study.
    Respir Res. 2022;23:109.
    PubMed     Abstract available


    April 2022
  81. YANG T, Cai B, Cao B, Kang J, et al
    Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study.
    Respir Res. 2022;23:106.
    PubMed     Abstract available


  82. HAWTHORNE G, Richardson M, Greening NJ, Esliger D, et al
    A proof of concept for continuous, non-invasive, free-living vital signs monitoring to predict readmission following an acute exacerbation of COPD: a prospective cohort study.
    Respir Res. 2022;23:102.
    PubMed     Abstract available


  83. GHOSH AJ, Hobbs BD, Yun JH, Saferali A, et al
    Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Respir Res. 2022;23:97.
    PubMed     Abstract available


  84. GUIOT J, Henket M, Frix AN, Gester F, et al
    Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
    Respir Res. 2022;23:89.
    PubMed     Abstract available


  85. ZOU J, Sun T, Song X, Liu YM, et al
    Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data.
    Respir Res. 2022;23:90.
    PubMed     Abstract available


  86. LI R, Chen Y, Zhao A, Huang L, et al
    Exploring genetic association of insomnia with allergic disease and asthma: a bidirectional Mendelian randomization study.
    Respir Res. 2022;23:84.
    PubMed     Abstract available


  87. GOMEZ N, James V, Onion D, Fairclough LC, et al
    Extracellular vesicles and chronic obstructive pulmonary disease (COPD): a systematic review.
    Respir Res. 2022;23:82.
    PubMed     Abstract available


  88. KELLY TL, Ward M, Pratt NL, Ramsay E, et al
    The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians.
    Respir Res. 2022;23:80.
    PubMed     Abstract available


    March 2022
  89. LEE KY, Wu SM, Kou HY, Chen KY, et al
    Association of air pollution exposure with exercise-induced oxygen desaturation in COPD.
    Respir Res. 2022;23:77.
    PubMed     Abstract available


  90. YU C, Huang W, Zhou Z, Liang S, et al
    Short isoform thymic stromal lymphopoietin reduces inflammation and aerobic glycolysis of asthmatic airway epithelium by antagonizing long isoform thymic stromal lymphopoietin.
    Respir Res. 2022;23:75.
    PubMed     Abstract available


  91. LU W, Tian Q, Xu R, Zhong C, et al
    Short-term exposure to ambient air pollution and pneumonia hospital admission among patients with COPD: a time-stratified case-crossover study.
    Respir Res. 2022;23:71.
    PubMed     Abstract available


  92. YU H, Lin Y, Zhong Y, Guo X, et al
    Impaired AT2 to AT1 cell transition in PM2.5-induced mouse model of chronic obstructive pulmonary disease.
    Respir Res. 2022;23:70.
    PubMed     Abstract available


  93. ROHL A, Baek SH, Kachroo P, Morrow JD, et al
    Protein interaction networks provide insight into fetal origins of chronic obstructive pulmonary disease.
    Respir Res. 2022;23:69.
    PubMed     Abstract available


  94. ZHANG XY, Li W, Zhang JR, Li CY, et al
    Roles of sirtuin family members in chronic obstructive pulmonary disease.
    Respir Res. 2022;23:66.
    PubMed     Abstract available


  95. HOFFMANN C, Maglakelidze M, von Schneidemesser E, Witt C, et al
    Asthma and COPD exacerbation in relation to outdoor air pollution in the metropolitan area of Berlin, Germany.
    Respir Res. 2022;23:64.
    PubMed     Abstract available


  96. HSU CW, Suk CW, Hsu YP, Chang JH, et al
    Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD.
    Respir Res. 2022;23:63.
    PubMed     Abstract available


  97. BRENNAN M, McDonnell MJ, Harrison MJ, Duignan N, et al
    Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines.
    Respir Res. 2022;23:58.
    PubMed     Abstract available


  98. SHIN SH, Kwon SO, Kim V, Silverman EK, et al
    Association of body mass index and COPD exacerbation among patients with chronic bronchitis.
    Respir Res. 2022;23:52.
    PubMed     Abstract available


  99. HUANG JJ, Yang XQ, Zhuo ZQ, Yuan L, et al
    Clinical characteristics of plastic bronchitis in children: a retrospective analysis of 43 cases.
    Respir Res. 2022;23:51.
    PubMed     Abstract available


  100. WEITOFT M, Kadefors M, Stenberg H, Tufvesson E, et al
    Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics.
    Respir Res. 2022;23:50.
    PubMed     Abstract available


  101. MIRAVITLLES M, Soler-Cataluna JJ, Soriano JB, Garcia-Rio F, et al
    Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study.
    Respir Res. 2022;23:49.
    PubMed     Abstract available


  102. KORN S, Howarth P, Smith SG, Price RG, et al
    Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma.
    Respir Res. 2022;23:45.
    PubMed     Abstract available


  103. BLASKOVIC S, Donati Y, Ruchonnet-Metrailler I, Avila Y, et al
    Early life exposure to nicotine modifies lung gene response after elastase-induced emphysema.
    Respir Res. 2022;23:44.
    PubMed     Abstract available


  104. DE VRIES M, Nwozor KO, Muizer K, Wisman M, et al
    The relation between age and airway epithelial barrier function.
    Respir Res. 2022;23:43.
    PubMed     Abstract available


  105. IRIE H, Ozaki M, Chubachi S, Hegab AE, et al
    Short-term intermittent cigarette smoke exposure enhances alveolar type 2 cell stemness via fatty acid oxidation.
    Respir Res. 2022;23:41.
    PubMed     Abstract available


    February 2022
  106. CHEN Y, Kong D, Fu J, Zhang Y, et al
    Associations between ambient temperature and adult asthma hospitalizations in Beijing, China: a time-stratified case-crossover study.
    Respir Res. 2022;23:38.
    PubMed     Abstract available


  107. MENZELLA F, Bargagli E, Aliani M, Bracciale P, et al
    ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
    Respir Res. 2022;23:36.
    PubMed     Abstract available


  108. KULBACKA-ORTIZ K, Triest FJJ, Franssen FME, Wouters EFM, et al
    Restricted spirometry and cardiometabolic comorbidities: results from the international population based BOLD study.
    Respir Res. 2022;23:34.
    PubMed     Abstract available


  109. SCHAUNAMAN N, Dimasuay KG, Kraft M, Chu HW, et al
    Tollip interaction with STAT3: a novel mechanism to regulate human airway epithelial responses to type 2 cytokines.
    Respir Res. 2022;23:31.
    PubMed     Abstract available


  110. MARQUES A, Souto-Miranda S, Machado A, Oliveira A, et al
    COPD profiles and treatable traits using minimal resources: identification, decision tree and stability over time.
    Respir Res. 2022;23:30.
    PubMed     Abstract available


  111. PARK SW, Lim MN, Kim WJ, Bak SH, et al
    Quantitative assessment the longitudinal changes of pulmonary vascular counts in chronic obstructive pulmonary disease.
    Respir Res. 2022;23:29.
    PubMed     Abstract available


  112. CUI Y, Zhan Z, Ma Y, Huang K, et al
    Clinical and economic burden of comorbid coronary artery disease in patients with acute exacerbation of chronic obstructive pulmonary disease: sex differences in a nationwide cohort study.
    Respir Res. 2022;23:28.
    PubMed     Abstract available


  113. WANG H, Zhong Y, Li N, Yu M, et al
    Transcriptomic analysis and validation reveal the pathogenesis and a novel biomarker of acute exacerbation of chronic obstructive pulmonary disease.
    Respir Res. 2022;23:27.
    PubMed     Abstract available


  114. SINGH D, Wild JM, Saralaya D, Lawson R, et al
    Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial.
    Respir Res. 2022;23:26.
    PubMed     Abstract available


    January 2022
  115. WU W, Gao J, Chen D, Chen G, et al
    Epithelial microRNA-30a-3p targets RUNX2/HMGB1 axis to suppress airway eosinophilic inflammation in asthma.
    Respir Res. 2022;23:17.
    PubMed     Abstract available


  116. MELO-DIAS S, Valente C, Andrade L, Marques A, et al
    Saliva as a non-invasive specimen for COPD assessment.
    Respir Res. 2022;23:16.
    PubMed     Abstract available


  117. KOO HK, Hoth KF, Make BJ, Regan EA, et al
    Optimism is associated with respiratory symptoms and functional status in chronic obstructive pulmonary disease.
    Respir Res. 2022;23:19.
    PubMed     Abstract available


  118. KLONT F, Horvatovich P, Bowler RP, van Rikxoort E, et al
    Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans.
    Respir Res. 2022;23:15.
    PubMed     Abstract available


  119. LUTHGEN M, Ruller S, Herzmann C
    Characteristics of the deventilation syndrome in COPD patients treated with non-invasive ventilation: an explorative study.
    Respir Res. 2022;23:13.
    PubMed     Abstract available


  120. HUANG X, Guan W, Xiang B, Wang W, et al
    MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model.
    Respir Res. 2022;23:11.
    PubMed     Abstract available


  121. CHIU YC, Lee SW, Liu CW, Lan TY, et al
    Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study.
    Respir Res. 2022;23:10.
    PubMed     Abstract available


  122. HO T, Nichols M, Nair G, Radford K, et al
    Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease.
    Respir Res. 2022;23:8.
    PubMed     Abstract available


  123. ZHU Z, Lian X, Su X, Wu W, et al
    Exosomes derived from adipose-derived stem cells alleviate cigarette smoke-induced lung inflammation and injury by inhibiting alveolar macrophages pyroptosis.
    Respir Res. 2022;23:5.
    PubMed     Abstract available


  124. LOMMATZSCH M, Speer T, Herr C, Jorres RA, et al
    IgE is associated with exacerbations and lung function decline in COPD.
    Respir Res. 2022;23:1.
    PubMed     Abstract available


    December 2021
  125. TIAN F, Song W, Wang L, Zeng Q, et al
    NT-pro BNP in AECOPD-PH: old biomarker, new insights-based on a large retrospective case-controlled study.
    Respir Res. 2021;22:321.
    PubMed     Abstract available


  126. MCKENZIE J, Nisha P, Cannon-Bailey S, Cain C, et al
    Overnight variation in tidal expiratory flow limitation in COPD patients and its correction: an observational study.
    Respir Res. 2021;22:319.
    PubMed     Abstract available


  127. HERNANDEZ CORDERO AI, Yang CX, Li X, Milne S, et al
    Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease.
    Respir Res. 2021;22:316.
    PubMed     Abstract available


  128. SKIBBA ME, Xu X, Weiss K, Huisken J, et al
    Role of Secretoglobin(+) (club cell) NFkappaB/RelA-TGFbeta signaling in aero-allergen-induced epithelial plasticity and subepithelial myofibroblast transdifferentiation.
    Respir Res. 2021;22:315.
    PubMed     Abstract available


  129. MASPERO J, Agache IO, Kamei T, Yoshida M, et al
    Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial.
    Respir Res. 2021;22:311.
    PubMed     Abstract available


  130. BURBANK AJ, Schworer SA, Sood A, Almond M, et al
    Airway IL-1beta associates with IL-5 production following dust mite allergen inhalation in humans.
    Respir Res. 2021;22:309.
    PubMed     Abstract available


    November 2021
  131. KOSHY K, Sha J, Bennetts K, Langton D, et al
    Safety of delivering bronchial thermoplasty in two treatment sessions.
    Respir Res. 2021;22:307.
    PubMed     Abstract available


  132. CUI Y, Zhang W, Ma Y, Zhan Z, et al
    Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study.
    Respir Res. 2021;22:301.
    PubMed     Abstract available


  133. JOO DH, Lee KH, Lee CH, Woo J, et al
    Developmental endothelial locus-1 as a potential biomarker for the incidence of acute exacerbation in patients with chronic obstructive pulmonary disease.
    Respir Res. 2021;22:297.
    PubMed     Abstract available


  134. SCHMIDT J, Martin A, Wenzel C, Weber J, et al
    Control of the expiratory flow in a lung model and in healthy volunteers with an adjustable flow regulator: a combined bench and randomized crossover study.
    Respir Res. 2021;22:292.
    PubMed     Abstract available


  135. SVERRILD A, Leadbetter J, Porsbjerg C
    The use of the mannitol test as an outcome measure in asthma intervention studies: a review and practical recommendations.
    Respir Res. 2021;22:287.
    PubMed     Abstract available


  136. SU X, Chen J, Lin X, Chen X, et al
    FERMT3 mediates cigarette smoke-induced epithelial-mesenchymal transition through Wnt/beta-catenin signaling.
    Respir Res. 2021;22:286.
    PubMed     Abstract available


    October 2021
  137. VOGELMEIER CF, Jones PW, Kerwin EM, Boucot IH, et al
    Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.
    Respir Res. 2021;22:279.
    PubMed     Abstract available


  138. HARDING JN, Gross M, Patel V, Potter S, et al
    Association between particulate matter containing EPFRs and neutrophilic asthma through AhR and Th17.
    Respir Res. 2021;22:275.
    PubMed     Abstract available


  139. YOSHIZAKI A, Nagano T, Izumi S, Nishiuma T, et al
    Characteristics of the nocturnal desaturation waveform pattern of SpO2 in COPD patients: an observational study.
    Respir Res. 2021;22:276.
    PubMed     Abstract available


  140. NG J, Pacheco-Rodriguez G, Begley L, Huang YJ, et al
    The lung microbiome in end-stage Lymphangioleiomyomatosis.
    Respir Res. 2021;22:277.
    PubMed     Abstract available


  141. LI N, Dai Z, Wang Z, Deng Z, et al
    Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.
    Respir Res. 2021;22:274.
    PubMed     Abstract available


  142. CHAPMAN KR, Wise RA, Scirica BM, Bhatt DL, et al
    Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers.
    Respir Res. 2021;22:272.
    PubMed     Abstract available


  143. SHIRAISHI M, Higashimoto Y, Sugiya R, Mizusawa H, et al
    Diaphragmatic excursion is correlated with the improvement in exercise tolerance after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.
    Respir Res. 2021;22:271.
    PubMed     Abstract available


  144. TUPPER OD, Ulrik CS
    Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma.
    Respir Res. 2021;22:269.
    PubMed     Abstract available


  145. QIU M, Jiang J, Nian X, Wang Y, et al
    Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    Respir Res. 2021;22:264.
    PubMed     Abstract available


  146. CARSTENSEN S, Gress C, Erpenbeck VJ, Kazani SD, et al
    Prostaglandin D2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP2 receptor.
    Respir Res. 2021;22:262.
    PubMed     Abstract available


  147. USMANI O, Roche N, Wahab E, Israel S, et al
    A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease.
    Respir Res. 2021;22:261.
    PubMed     Abstract available


  148. CARL J, Schultz K, Janssens T, von Leupoldt A, et al
    The "can do, do do" concept in individuals with chronic obstructive pulmonary disease: an exploration of psychological mechanisms.
    Respir Res. 2021;22:260.
    PubMed     Abstract available


    August 2021
  149. HUBER MB, Schneider N, Kirsch F, Schwarzkopf L, et al
    Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life.
    Respir Res. 2021;22:226.
    PubMed     Abstract available


  150. VOGT S, Leuppi JD, Schuetz P, Mueller B, et al
    Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial.
    Respir Res. 2021;22:227.
    PubMed     Abstract available


  151. HSU HT, Wu CD, Chung MC, Shen TC, et al
    The effects of traffic-related air pollutants on chronic obstructive pulmonary disease in the community-based general population.
    Respir Res. 2021;22:217.
    PubMed     Abstract available


    July 2021
  152. LONG H, Xu H, Janssens JP, Guo Y, et al
    Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials.
    Respir Res. 2021;22:209.
    PubMed     Abstract available


  153. PU X, Liu L, Feng B, Zhang Z, et al
    Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis.
    Respir Res. 2021;22:201.
    PubMed     Abstract available


  154. HARBAUM L, Hennigs JK, Simon M, Oqueka T, et al
    Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study.
    Respir Res. 2021;22:199.
    PubMed     Abstract available


  155. VAN DEN BERGE M, De Backer J, Van Holsbeke C, De Backer W, et al
    Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids.
    Respir Res. 2021;22:191.
    PubMed     Abstract available


  156. ZHU J, Wang F, Feng X, Li B, et al
    Family with sequence similarity 13 member A mediates TGF-beta1-induced EMT in small airway epithelium of patients with chronic obstructive pulmonary disease.
    Respir Res. 2021;22:192.
    PubMed     Abstract available


    June 2021
  157. MURO S, Sugiura H, Darken P, Dorinsky P, et al
    Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts.
    Respir Res. 2021;22:187.
    PubMed     Abstract available


  158. KOARAI A, Yamada M, Ichikawa T, Fujino N, et al
    Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis.
    Respir Res. 2021;22:183.
    PubMed     Abstract available


  159. MURO S, Suzuki M, Nakamura S, Wang JR, et al
    Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysis.
    Respir Res. 2021;22:180.
    PubMed     Abstract available


  160. GU Y, Ye X, Liu Y, Wang Y, et al
    A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Respir Res. 2021;22:176.
    PubMed     Abstract available


  161. ANDELID K, Ost K, Andersson A, Mohamed E, et al
    Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis.
    Respir Res. 2021;22:172.
    PubMed     Abstract available


    May 2021
  162. SIVAPALAN P, Rutishauser J, Ulrik CS, Leuppi JD, et al
    Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
    Respir Res. 2021;22:155.
    PubMed     Abstract available


  163. ZHENG ZG, Sun WZ, Hu JY, Jie ZJ, et al
    Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial.
    Respir Res. 2021;22:149.
    PubMed     Abstract available


  164. JACOBSEN PA, van 't Hul AJ, Djamin RS, Antons JC, et al
    Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employment.
    Respir Res. 2021;22:147.
    PubMed     Abstract available


  165. WEISS DJ, Segal K, Casaburi R, Hayes J, et al
    Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.
    Respir Res. 2021;22:142.
    PubMed     Abstract available


  166. GLOECKL R, Schneeberger T, Leitl D, Reinold T, et al
    Whole-body vibration training versus conventional balance training in patients with severe COPD-a randomized, controlled trial.
    Respir Res. 2021;22:138.
    PubMed     Abstract available


    April 2021
  167. HEALY C, Munoz-Wolf N, Strydom J, Faherty L, et al
    Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.
    Respir Res. 2021;22:133.
    PubMed     Abstract available


  168. SINGH D, Criner GJ, Dransfield MT, Halpin DMG, et al
    InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
    Respir Res. 2021;22:130.
    PubMed     Abstract available


  169. PRATTE KA, Curtis JL, Kechris K, Couper D, et al
    Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Respir Res. 2021;22:127.
    PubMed     Abstract available


  170. MAJORSKI DS, Magnet FS, Thilemann S, Schmoor C, et al
    Portable NIV for patients with moderate to severe COPD: two randomized crossover trials.
    Respir Res. 2021;22:123.
    PubMed     Abstract available


  171. ZHANG WZ, Hoffman KL, Schiffer KT, Oromendia C, et al
    Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.
    Respir Res. 2021;22:126.
    PubMed     Abstract available


  172. SINGH R, Belchamber KBR, Fenwick PS, Chana K, et al
    Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD.
    Respir Res. 2021;22:113.
    PubMed     Abstract available


  173. KIM V, Dolliver WR, Nath HP, Grumley SA, et al
    Mucus plugging on computed tomography and chronic bronchitis in chronic obstructive pulmonary disease.
    Respir Res. 2021;22:110.
    PubMed    


  174. LI X, Noell G, Tabib T, Gregory AD, et al
    Single cell RNA sequencing identifies IGFBP5 and QKI as ciliated epithelial cell genes associated with severe COPD.
    Respir Res. 2021;22:100.
    PubMed     Abstract available


    March 2021
  175. CHUBACHI S, Yamada Y, Yamada M, Yokoyama Y, et al
    Differences in airway lumen area between supine and upright computed tomography in patients with chronic obstructive pulmonary disease.
    Respir Res. 2021;22:95.
    PubMed     Abstract available


  176. MACHADO FVC, Spruit MA, Groenen MTJ, Houben-Wilke S, et al
    Frequency and functional translation of low muscle mass in overweight and obese patients with COPD.
    Respir Res. 2021;22:93.
    PubMed     Abstract available


  177. PAN K, Lu J, Song Y
    Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-gamma/TGF-beta1/Smad2/3 signalling pathway.
    Respir Res. 2021;22:91.
    PubMed     Abstract available


  178. ZHENG J, Baldi S, Zhao L, Li H, et al
    Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.
    Respir Res. 2021;22:90.
    PubMed     Abstract available


  179. PARK HJ, Kim SR, Kim S, Lee HS, et al
    Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease.
    Respir Res. 2021;22:87.
    PubMed     Abstract available


  180. SERRE J, Tanjeko AT, Mathyssen C, Vanherwegen AS, et al
    Enhanced lung inflammatory response in whole-body compared to nose-only cigarette smoke-exposed mice.
    Respir Res. 2021;22:86.
    PubMed     Abstract available


  181. BLERVAQUE L, Prefaut C, Forthin H, Maffre F, et al
    Efficacy of a long-term pulmonary rehabilitation maintenance program for COPD patients in a real-life setting: a 5-year cohort study.
    Respir Res. 2021;22:79.
    PubMed     Abstract available


  182. CAO Y, Xing Z, Long H, Huang Y, et al
    Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit.
    Respir Res. 2021;22:77.
    PubMed     Abstract available


    February 2021
  183. PEROTIN JM, Polette M, Deslee G, Dormoy V, et al
    CiliOPD: a ciliopathy-associated COPD endotype.
    Respir Res. 2021;22:74.
    PubMed     Abstract available


  184. LI LY, Yan TS, Yang J, Li YQ, et al
    Impulse oscillometry for detection of small airway dysfunction in subjects with chronic respiratory symptoms and preserved pulmonary function.
    Respir Res. 2021;22:68.
    PubMed     Abstract available


  185. MALVISI L, Taddei L, Yarraguntla A, Wilkinson TMA, et al
    Sputum sample positivity for Haemophilus influenzae or Moraxella catarrhalis in acute exacerbations of chronic obstructive pulmonary disease: evaluation of association with positivity at earlier stable disease timepoints.
    Respir Res. 2021;22:67.
    PubMed     Abstract available


  186. GULEA C, Zakeri R, Alderman V, Morgan A, et al
    Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison.
    Respir Res. 2021;22:64.
    PubMed     Abstract available


  187. YANG N, Singhera GK, Yan YX, Pieper MP, et al
    Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells.
    Respir Res. 2021;22:65.
    PubMed     Abstract available


  188. PISON C, Shah PL, Slebos DJ, Ninane V, et al
    Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes.
    Respir Res. 2021;22:62.
    PubMed     Abstract available


  189. SAITO T, Ichikawa T, Numakura T, Yamada M, et al
    PGC-1alpha regulates airway epithelial barrier dysfunction induced by house dust mite.
    Respir Res. 2021;22:63.
    PubMed     Abstract available


  190. CHEN W, Sadatsafavi M, FitzGerald JM, Lynd LD, et al
    Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis.
    Respir Res. 2021;22:59.
    PubMed     Abstract available


  191. CORDOBA-LANUS E, Cazorla-Rivero S, Garcia-Bello MA, Mayato D, et al
    Telomere length dynamics over 10-years and related outcomes in patients with COPD.
    Respir Res. 2021;22:56.
    PubMed     Abstract available


  192. SAVRAN O, Godtfredsen N, Sorensen T, Jensen C, et al
    COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
    Respir Res. 2021;22:54.
    PubMed     Abstract available


  193. KANG J, Lee JS, Lee SW, Lee JB, et al
    Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials.
    Respir Res. 2021;22:55.
    PubMed     Abstract available


  194. VAN DEN BERG MPM, Nijboer-Brinksma S, Bos IST, van den Berge M, et al
    The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.
    Respir Res. 2021;22:48.
    PubMed     Abstract available


  195. WANG Y, Liao K, Liu B, Niu C, et al
    GITRL on dendritic cells aggravates house dust mite-induced airway inflammation and airway hyperresponsiveness by modulating CD4(+) T cell differentiation.
    Respir Res. 2021;22:46.
    PubMed     Abstract available


  196. KIM J, Kim B, Bak SH, Oh YM, et al
    A comparative study of chest CT findings regarding the effects of regional dust exposure on patients with COPD living in urban areas and rural areas near cement plants.
    Respir Res. 2021;22:43.
    PubMed     Abstract available


  197. SONG Q, Chen P, Liu XM
    The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD.
    Respir Res. 2021;22:39.
    PubMed     Abstract available


  198. CALLE RUBIO M, Rodriguez Hermosa JL, de Torres JP, Marin JM, et al
    COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort.
    Respir Res. 2021;22:36.
    PubMed     Abstract available


  199. GALDI F, Pedone C, McGee CA, George M, et al
    Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study.
    Respir Res. 2021;22:30.
    PubMed     Abstract available


    January 2021
  200. LEMAIRE F, Audonnet S, Perotin JM, Gaudry P, et al
    The elastin peptide VGVAPG increases CD4(+) T-cell IL-4 production in patients with chronic obstructive pulmonary disease.
    Respir Res. 2021;22:14.
    PubMed     Abstract available


  201. BAGGE K, Sivapalan P, Eklof J, Hertz FB, et al
    Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid-data from 43,636 outpatients.
    Respir Res. 2021;22:11.
    PubMed     Abstract available


  202. MAO X, Liang C, Niu H, Dong F, et al
    Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry.
    Respir Res. 2021;22:7.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: